[go: up one dir, main page]

About: Dimitri Azar

An Entity of Type: animal, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.

Property Value
dbo:abstract
  • Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018. (en)
dbo:almaMater
dbo:institution
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 58056021 (xsd:integer)
dbo:wikiPageLength
  • 18025 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1117919836 (xsd:integer)
dbo:wikiPageWikiLink
dbp:almaMater
  • American University of Beirut, Lebanon; Wilmer Eye Institute, Johns Hopkins Hospital School of Medicine; Massachusetts Eye and Ear Infirmary, Harvard Medical School; University of Chicago Booth School of Business (en)
dbp:birthDate
  • 1959 (xsd:integer)
dbp:date
  • 2018-08-03 (xsd:date)
dbp:fields
  • Ophthamology (en)
dbp:url
dbp:wikiPageUsesTemplate
dbp:workplaces
  • University of Illinois at Chicago; American Ophthalmological Society; Chicago Ophthalmological Society; Chicago Medical Society; Association of Research in Vision and Ophthalmology; Verily; Verb Surgical Inc; Tear Film and Ocular Surface Society; Novartis (en)
dct:subject
rdf:type
rdfs:comment
  • Dimitri Azar M.D. (born 1959) is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018. (en)
rdfs:label
  • Dimitri Azar (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License